TNF-α inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway
Nature - 12 May 2025TNF-α inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway ...
epstein barr virus
TNF-α inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway ...
Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation
Science | AAAS - 29 Jan 2025Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation ...
Scientists identify new strategy to fight cancer caused by Epstein-Barr virus
Medical Xpress - 10 Mar 2025Scientists identify new strategy to fight cancer caused by Epstein-Barr virus ...
Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation - eBioMedicine
The Lancet - 24 Apr 2025Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation - eBioMedicine ...
NK cell leukemia (ANKL): Symptoms, causes, and treatment
Medical News Today - 12 May 2025NK cell leukemia (ANKL): Symptoms, causes, and treatment ...
Epstein–Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging
PNAS - 10 Mar 2025Epstein–Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging ...
Higher cancer risk for kidney transplant recipients linked to EBV
Penn Medicine - 10 Feb 2025Higher cancer risk for kidney transplant recipients linked to EBV ...
Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus
Penn Today - 19 Feb 2025Increased cancer risk for kidney transplant recipients linked to Epstein-Barr virus ...
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
OPKO Health, Inc. - 07 Jan 2025OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck ...
Epstein-Barr virus may drive MS by dysregulating certain immune cells
Multiple Sclerosis News Today - 12 Mar 2025Epstein-Barr virus may drive MS by dysregulating certain immune cells ...
Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization
ScienceDirect.com - 28 Jan 2025Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization ...
Epstein–Barr virus pathogenesis and emerging control strategies
Nature - 25 Apr 2025Epstein–Barr virus pathogenesis and emerging control strategies ...
Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation
PNAS - 23 Jan 2025Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation ...
Study reveals surprising link between Crohn's disease and the Epstein-Barr virus
Medical Xpress - 03 Mar 2025Study reveals surprising link between Crohn's disease and the Epstein-Barr virus ...
Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms
ScienceDirect.com - 22 Oct 2024Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms ...
Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation | Signal Transduction and Targeted Therapy
Nature - 10 Mar 2025Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation | Signal Transduction and Targeted Therapy ...
Viral oncogenesis in cancer: from mechanisms to therapeutics
Nature - 12 May 2025Viral oncogenesis in cancer: from mechanisms to therapeutics ...
Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression
Nature - 04 Dec 2024Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression ...
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylax
Nature - 03 Mar 2025Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylax ...